Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome

Adam S Kittai; David A Bond; Basem William; Ayman Saad; Sam Penza; Yvonne Efebera; Karilyn Larkin; Sarah A Wall; Hannah K Choe; Bhavana Bhatnagar; Sumithira Vasu; Jonathan Brammer; Polina Shindiapina; Meixiao Long; Alice Mims; Lynn O'Donnell; Seema A Bhat; Kerry A Rogers; Jennifer A Woyach; John C Byrd; Samantha M Jaglowski

doi:10.1182/bloodadvances.2020002783

Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome

Blood Adv. 2020 Oct 13;4(19):4648-4652. doi: 10.1182/bloodadvances.2020002783.

Authors

Adam S Kittai^{1

2

3}, David A Bond^{1

2

3}, Basem William^{1

2

3}, Ayman Saad^{1

2

3}, Sam Penza^{1

2

3}, Yvonne Efebera^{1

2

3}, Karilyn Larkin^{1

2

3}, Sarah A Wall^{1

2

3}, Hannah K Choe^{1

2

3}, Bhavana Bhatnagar^{1

2

3}, Sumithira Vasu^{1

2

3}, Jonathan Brammer^{1

2

3}, Polina Shindiapina^{1

2

3}, Meixiao Long^{1

2

3}, Alice Mims^{1

2

3}, Lynn O'Donnell^{1

2

3}, Seema A Bhat^{1

2

3}, Kerry A Rogers^{1

2

3}, Jennifer A Woyach^{1

2

3

4}, John C Byrd^{1

2

3

4}, Samantha M Jaglowski^{1

2

3}

Affiliations

¹ Division of Hematology, Department of Internal Medicine.
² Arthur G. James Comprehensive Cancer Center.
³ Wexner Medical Center, and.
⁴ Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, OH.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antigens, CD19 / therapeutic use
Biological Products
Humans
Immunotherapy, Adoptive
Leukemia, Lymphocytic, Chronic, B-Cell*
Lymphoma, Large B-Cell, Diffuse*

Substances

Antigens, CD19
Biological Products
axicabtagene ciloleucel